The Expert group rejected the Pfizer Vaccine for emergency approval in India as it did not meet the basic condition of conducting adequate tests on a sample of Indian users. Pfizer has also agreed to conduct the necessary tests and then reapply for approval. However, there are two additional constraints to the Pfizer vaccine in